Joan Chypyha

Joan Chypyha

Director/Board Member at OVATION SCIENCE INC.

Net worth: 1 537 $ as of 31/08/2026

60 year
Health Technology
Consumer Services
Consumer Non-Durables

Profile

Joan Chypyha is the founder of Alto Pharmaceuticals Ltd., founded in 2008, serving as President & Chief Executive Officer.
Current jobs include Independent Director at Ovation Science, Inc. (Canada) since 2018 and Independent Director at Edesa Biotech, Inc. since 2023.
Former jobs include Director at Canadian Healthcare Licensing Association, President at Cipher Pharmaceuticals, Inc. from 2013 to 2017, Chief Business Development Officer at Rhei Pharmaceuticals Ltd. from 2009 to 2011, VP-Corporate Development & General Manager at Barrier Therapeutics Canada, Inc. from 2004 to 2008, and President at Canadian Dermatology Association from 2015 to 2023.
Education includes an MBA from Queen's University and an undergraduate degree from the University of Toronto.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
20/10/2025 200,000 ( 0.52% ) 1 400 $ 31/08/2026
27/05/2026 29 ( 0% ) 137 $ 31/08/2026

Joan Chypyha active positions

CompaniesPositionStart
OVATION SCIENCE INC. Director/Board Member 02/02/2018
EDESA BIOTECH, INC. Director/Board Member 23/05/2023
Chief Executive Officer 01/01/2008

Former positions of Joan Chypyha

CompaniesPositionEnd
President 01/01/2023
CIPHER PHARMACEUTICALS INC. President 02/06/2017
Rhei Pharmaceuticals Ltd.
Corporate Officer/Principal 01/01/2011
Barrier Therapeutics Canada, Inc.
Corporate Officer/Principal 01/08/2008
Canadian Healthcare Licensing Association
Director/Board Member -
See the detail of Joan Chypyha's experience

Training of Joan Chypyha

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

46

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Consumer Services

Canadian Healthcare Licensing Association

Health Technology

Consumer Non-Durables

Rhei Pharmaceuticals Ltd.

Barrier Therapeutics Canada, Inc.

Health Technology

Commercial Services

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!